SCHEMBL29740501

SCHEMBL29740501

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 17/20 0.59
▸ IL23R Q5VWK5 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29434537 0.90 GLP1R (0.57) GLP1RIL23R
SCHEMBL30208638 0.90 GLP1R (0.57) GLP1RIL23R
SCHEMBL29613390 0.89 IL23R (0.55) GLP1RIL23R
SCHEMBL30932144 0.89 GLP1R (0.59) GLP1R
SCHEMBL30216222 0.88 GLP1R (0.52) GLP1RIL23R
SCHEMBL30064553 0.88 GLP1R (0.58) GLP1RIL23R
SCHEMBL30932143 0.87 GLP1R (0.60) GLP1R
SCHEMBL30607301 0.87 IL23R (0.62) GLP1RIL23R
SCHEMBL31182987 0.87 GLP1R (0.71) GLP1R
SCHEMBL29484311 0.87 GLP1R (0.56) GLP1RIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240218018-A1 Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-07-04 — — US disclosed
US-11884747-B2 Compstatin analogs with increased solubility and improved pharmacokinetic properties THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-01-30 — — US disclosed
EP-4011905-A2 COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES The Trustees Of The University Of Pennsylvania (US) 2022-06-15 — — EP disclosed
Send feedback